Beryl Drugs Limited (BOM:524606)

Market Cap	112.85M
Revenue (ttm)	191.97M
Net Income (ttm)	2.34M
Shares Out	5.07M
EPS (ttm)	0.46
PE Ratio	48.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	954
Average Volume	844
Open	22.90
Previous Close	22.90
Day's Range	21.50 - 22.90
52-Week Range	17.35 - 43.00
Beta	0.04
RSI	47.71
Earnings Date	Feb 6, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In 2024, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.